보툴리눔톡신(보톡스) 시장 규모, 점유율, 성장 분석, 제품별, 용도별, 최종사용자별, 지역별 - 산업 예측(2024-2031년)
Botulinum Toxin Market Size, Share, Growth Analysis, By Product (Type A, Type B), By Application (Aesthetic, Therapeutic), By End User (Hospitals, Dermatology Clinics), By Region - Industry Forecast 2024-2031
상품코드 : 1566212
리서치사 : SkyQuest
발행일 : 2024년 10월
페이지 정보 : 영문 165 Pages
 라이선스 & 가격 (부가세 별도)
US $ 5,300 ₩ 7,704,000
PDF & Excel (Single User License) help
PDF 및 Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,200 ₩ 9,012,000
PDF & Excel (Multiple User License) help
PDF 및 Excel 보고서를 동일 사업장에서 2-5명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 7,100 ₩ 10,321,000
PDF & Excel (Enterprise License) help
PDF 및 Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


한글목차

세계의 보툴리눔톡신(보톡스) 시장 규모는 2022년에 100억 1,000만 달러에 달하며, 예측 기간(2024-2031년)의 CAGR은 9.83%로, 2023년 111억 2,000만 달러에서 2031년까지는 235억 4,000만 달러로 성장할 전망입니다.

세계의 보툴리눔톡신(보톡스, BNT) 시장은 현재의 용도뿐만 아니라 치료용도 확대를 위한 연구개발의 발전과 미용 및 비침습적 시술에 대한 수요 증가로 인해 큰 성장이 예상되며, 7가지 항원형으로 구성된 주목할 만한 제품으로는 BNT-A의 한정된 제품군 및 BNT-B의 단일 제품이 있으며, 시장 다변화와 혁신의 가능성을 강조하고 있습니다. 신제품 출시 추세는 환자 부담 경감 개선과 보툴리눔 주사에 대한 보험 적용을 포함한 보험 적용 정책의 발전과 함께 이러한 성장을 더욱 촉진하고 있습니다. 미용 치료에 대한 소비자의 관심이 눈에 띄게 증가함에 따라 미국 보툴리눔 톡신 시장은 향후 예측 기간 중 지속적인 CAGR을 나타낼 것으로 예상됩니다. 기업이 R&D에 대한 전략적 투자를 통해 제품 포트폴리오를 강화하고 미용 및 치료 분야에서 보툴리눔 톡신이 더 널리 받아들여질 수 있도록할 것으로 보입니다. 전반적으로 이러한 요인들이 복합적으로 작용하여 보툴리눔 톡신 시장의 미래는 유망하며, 헬스케어 산업에서 역동적인 분야로 자리매김할 것으로 보입니다.

목차

서론

조사 방법

개요

시장 역학과 전망

주요 시장 인사이트

보툴리눔톡신(보톡스) 시장 : 제품별

보툴리눔톡신(보톡스) 시장 : 용도별

보툴리눔톡신(보톡스) 시장 : 최종사용자별

보툴리눔톡신(보톡스) 시장 규모 : 지역별

경쟁 구도

주요 기업 개요

KSA
영문 목차

영문목차

Global Botulinum Toxin Market size was valued at USD 10.01 billion in 2022 and is poised to grow from USD 11.12 billion in 2023 to USD 23.54 billion by 2031, growing at a CAGR of 9.83% during the forecast period (2024-2031).

The global botulinum toxin (BNT) market is poised for significant growth, driven by increasing demand for cosmetic and non-invasive procedures, alongside advancements in research and development aimed at expanding therapeutic applications beyond its current uses. Comprising seven antigenic forms, notable products include a limited array of BNT-A and a singular BNT-B offering, underscoring the potential for market diversification and innovation. The trend towards new product launches, coupled with improving patient affordability and evolving reimbursement policies that now include coverage for botulinum injections, further propels this growth. With a notable increase in consumer interest in aesthetic treatments, the U.S. market for botulinum toxin is expected to experience a sustainable compound annual growth rate (CAGR) in the forthcoming forecast period. As companies invest strategically in R&D, this will enhance the product portfolio and encourage broader acceptance of botulinum toxin in both cosmetic and therapeutic domains. Overall, the confluence of these factors suggests a promising trajectory ahead for the botulinum toxin market, positioning it as a dynamic segment within the healthcare industry.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Botulinum Toxin market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Botulinum Toxin Market Segmental Analysis

Global Botulinum Toxin Market is segmented by Product, Application, End User, and Region. Based on Product, the market is segmented into Type A (Botox, Dysport, Xeomin, Others), Type B. Based on Application, the market is segmented into Therapeutic (Chronic Migraine, Overactive Bladder, Cervical Dystonia, Spasticity, Others), Aesthetic (Glabellar Lines, Crow's Feet, Forehead Lines, Others). Based on End User, the market is segmented into Hospitals, Dermatology Clinics, Cosmetic Centers and Medspas. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Botulinum Toxin Market

The increasing demand for minimally invasive cosmetic procedures is a significant market driver for the global botulinum toxin market. As more individuals seek non-surgical options to achieve youthful appearances with minimal recovery time, botulinum toxin treatments have become increasingly popular for reducing wrinkles and fine lines. This trend is further fueled by a growing awareness of the benefits of aesthetic procedures, enhanced by social media influence and celebrity endorsements. Additionally, advancements in technology and product formulations have improved the effectiveness and safety of botulinum toxin therapies, thereby expanding their application in both cosmetic and therapeutic settings, propelling market growth.

Restraints in the Global Botulinum Toxin Market

The global botulinum toxin market may face significant restraints due to the potential side effects associated with its use. Adverse reactions, including muscle weakness, allergic reactions, and localized pain, can deter patients from seeking treatments, thus impacting market growth. Additionally, the perception of safety risks can influence healthcare professionals' recommendations, further complicating patient acceptance. Regulatory scrutiny surrounding the approval and marketing of botulinum toxin products may also pose challenges, as companies must navigate stringent guidelines while addressing concerns related to side effects. The cumulative effect of these factors could inhibit the expansion of the market and limit its overall potential.

Market Trends of the Global Botulinum Toxin Market

The global botulinum toxin market is witnessing significant growth, driven predominantly by cosmetic procedures favored by women, who constitute a remarkable 92% of all treatments. With a rising number of individuals over 40 prioritizing their physical appearance, especially in developed nations, the demand for aesthetics enhancements continues to surge. This trend is emphasized by the remarkable statistic of over 2.5 million women aged 40-54 undergoing botulinum toxin procedures in 2020 alone. As societal norms around beauty evolve, this market trend indicates robust prospects for botulinum toxin, with a sustained focus on anti-aging solutions likely to propel its expansion well into the future.

Table of Contents

Introduction

Research Methodology

Executive Summary

Market Dynamics & Outlook

Key Market Insights

Botulinum Toxin Market, By Product

Botulinum Toxin Market, By Application

Botulinum Toxin Market, By End User

Botulinum Toxin Market Size by Region

Competitive Landscape

Key Company Profiles

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기